Alpine Associates Management Inc. Vigil Neuroscience, Inc. Transaction History
Alpine Associates Management Inc.
- $1.83 Billion
- Q2 2025
A detailed history of Alpine Associates Management Inc. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Alpine Associates Management Inc. holds 1,094,900 shares of VIGL stock, worth $8.81 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
1,094,900Holding current value
$8.81 Million% of portfolio
0.47%Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
61Shares Held
29.1MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$47 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$32.3 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$15.8 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$14 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...